Tinzaparin Sodium

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	24.9%
Diffuse Large B-cell Lymphoma	13.9%
Pulmonary Embolism	8.7%
Acute Coronary Syndrome	6.9%
Non-small Cell Lung Cancer	6.9%
Non-hodgkin's Lymphoma	5.8%
Prostate Cancer	5.2%
Thrombosis Prophylaxis	5.2%
Ventricular Dysfunction	4.6%
Deep Vein Thrombosis	4.0%
Colon Cancer	2.3%
Pulmonary Infarction	2.3%
Epilepsy	1.7%
Erysipelas	1.7%
Supraventricular Tachycardia	1.7%
Ankylosing Spondylitis	1.2%
Prophylaxis	1.2%
Anxiety	0.6%
Conjunctivitis	0.6%
Drug Use For Unknown Indication	0.6%

Epistaxis	10.5%
Thrombosis	10.5%
Upper Gastrointestinal Haemorrhage	10.5%
Hypertension	7.9%
Toxic Epidermal Necrolysis	7.9%
Cerebral Haemorrhage	5.3%
Drug Rash With Eosinophilia And Systemic Symptoms	5.3%
Haematuria	5.3%
Priapism	5.3%
Sciatica	5.3%
Cholestasis	2.6%
Condition Aggravated	2.6%
Disability	2.6%
Haematoma	2.6%
Hidradenitis	2.6%
Hyperkalaemia	2.6%
Metrorrhagia	2.6%
Peripheral Artery Aneurysm	2.6%
Skeletal Injury	2.6%
Thrombocytopenia	2.6%

Concomitant

Product Used For Unknown Indication	15.5%
Drug Use For Unknown Indication	11.3%
Prophylaxis	9.7%
Hiv Infection	8.0%
Hypertension	6.7%
Non-small Cell Lung Cancer	6.2%
Arrhythmia	5.1%
Breast Cancer	5.1%
Thrombosis Prophylaxis	4.3%
Pain	3.8%
Ovarian Cancer Metastatic	3.2%
Chronic Obstructive Pulmonary Disease	2.7%
Abdominal Sepsis	2.4%
Blood Pressure	2.4%
Lung Neoplasm Malignant	2.4%
Metastatic Renal Cell Carcinoma	2.4%
Pancreatic Carcinoma	2.4%
Chemotherapy	2.1%
Colorectal Cancer	2.1%
Non-small Cell Lung Cancer Stage Iv	2.1%

Pneumonia	8.8%
Weight Decreased	8.8%
Septic Shock	7.4%
Cytolytic Hepatitis	5.9%
Drug Interaction	5.9%
Renal Failure	5.9%
Therapy Cessation	5.9%
Venous Thrombosis	5.9%
Atrial Fibrillation	4.4%
Dehydration	4.4%
Febrile Neutropenia	4.4%
Myalgia	4.4%
Pulmonary Embolism	4.4%
Transfusion Reaction	4.4%
Vomiting	4.4%
Acute Myocardial Infarction	2.9%
Bronchitis	2.9%
Cerebrovascular Accident	2.9%
Deep Vein Thrombosis	2.9%
Device Related Infection	2.9%